GEORGE SAMIH ABELA
Pharmacy in East Lansing, MI
License number
Michigan 5304000943
Issued Date
Mar 26, 2012
Expiration Date
Jun 30, 2013
Category
Pharmacy
Type
CS - Analytical Labs
Address
Address
East Lansing, MI 48824
Personal information
See more information about GEORGE SAMIH ABELA at radaris.comName
Address
Phone
25176 Rosenbusch Blvd, Warren, MI 48089
37155 Golfview Dr, Sterling Hts, MI 48312
56358 Cromwell Ct, Shelby Township, MI 48316
6201 Windrush Ln, East Lansing, MI 48823
Haslett, MI
Professional information
Dr. George S Abela, East Lansing MI - MD (Doctor of Medicine)
Specialties:
Cardiology
Address:
MI State Univ Crdlgy/Endcrnlgy
804 Service Rd SUITE A205, East Lansing 48824
(517) 353-4830 (Phone)
804 Service Rd SUITE A205, East Lansing 48824
(517) 353-4830 (Phone)
Procedures:
Ablation for Treatment of Cardiac Arrythmias, Cardiac Catheterization (incl. Coronary Angiography), Cardiac Imaging, Cardiac Myocardial Perfusion Imaging, Cardioverter-Defibrillator or Pacemaker Insertion, Removal or Repair, Chest CT (incl. Heart and Lungs), Coronary Angioplasty, Atherectomy and Stent, Peripheral Artery Catheterization
Conditions:
Angina and Acute Coronary Syndrome, Aortic Aneurysm, Aortic Valve Disease, Arrhythmias (incl. Atrial Fibrillation), Cardiomegaly, Cardiomyopathy, Carotid Artery Disease, Congenital Heart Disease, Congestive Heart Failure, Coronary Artery Disease (CAD), Endocarditis, Heart Attack (Acute Myocardial Infarction), Hyperlipidemia, Hypertension, Hypotension, Mitral Valve Disease, Pericardial Disease, Pulmonary Hypertension, Septal Defect, Syncope, Tricuspid Valve Disease
Certifications:
Cardiovascular Disease, 1987, Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
American University of Beirut / Faculty of Medicine
Emory University Hospital
U Fla Hosp
American University of Beirut / Faculty of Medicine
Emory University Hospital
U Fla Hosp
Novel Nano-Probes For Molecular Imaging And Targeted Therapy Of Diseases
US Patent:
2012010, May 3, 2012
Filed:
Apr 14, 2010
Appl. No.:
13/264823
Inventors:
Xuefei Huang - Okemos MI, US
David Zhu - East Lansing MI, US
George Abela - East Lansing MI, US
David Zhu - East Lansing MI, US
George Abela - East Lansing MI, US
International Classification:
A61K 49/00, A61K 49/04, A61K 49/18, A61P 9/10, A61K 31/366, A61K 31/655, A61K 51/12, A61K 31/713, B82Y 5/00
US Classification:
424 111, 424 94, 424 932, 424 96, 424 93, 514 44 A, 514451, 514150, 977773, 977928, 977930, 977927, 977906
Abstract:
The present inventions relate to compositions and methods for imaging and treating atherosclerotic diseases, pathogen infections, and tumors by administering actively targeting magnetic nanoparticles. In particular, the present inventions provide new types of targeting ligands attached to magnetic nanoparticles for magnetic resonance imaging. The use of these targeted magnetic nanoparticles is contemplated as a means to treat atherosclerotic diseases, including but not limited to inhibiting and removing atherosclerotic plaques. Further, actively targeting magnetic nanoparticles are contemplated for use with multiple labels for use in nuclear medicine imaging, computed tomography (CT) techniques and other types of imaging for medical and research applications.